Clinical Trial Update: To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer

View source ↗

Summary

A clinical trial update describing ongoing biomarker research to predict efficacy of QL1101 and bevacizumab in non-squamous non-small cell lung cancer by measur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• QL1101 (bevacizumab biosimilar)

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Non Small Cell Lung Cancer | Status: UNKNOWN